These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol)s conjugated at their distal terminals to monoclonal antibodies. Maruyama K; Takizawa T; Yuda T; Kennel SJ; Huang L; Iwatsuru M Biochim Biophys Acta; 1995 Mar; 1234(1):74-80. PubMed ID: 7880861 [TBL] [Abstract][Full Text] [Related]
7. [Study on preparation and biodistribution of PEG-immunoliposomes with active carboxylic terminals]. Zhang YF; Xie SS; Hou XP; Gao X; Zhang S; Chen ZS Yao Xue Xue Bao; 2000 Nov; 35(11):854-9. PubMed ID: 11218866 [TBL] [Abstract][Full Text] [Related]
8. Preparation of long-circulating immunoliposomes containing adriamycin by a novel method to coat immunoliposomes with poly(ethylene glycol). Suzuki S; Watanabe S; Masuko T; Hashimoto Y Biochim Biophys Acta; 1995 Aug; 1245(1):9-16. PubMed ID: 7654771 [TBL] [Abstract][Full Text] [Related]
9. Preparation of long-circulating immunoliposomes using PEG-cholesterol conjugates: effect of the spacer arm between PEG and cholesterol on liposomal characteristics. Carrion C; Domingo JC; de Madariaga MA Chem Phys Lipids; 2001 Nov; 113(1-2):97-110. PubMed ID: 11687230 [TBL] [Abstract][Full Text] [Related]
10. Immunoliposomes and PEGylated immunoliposomes: possible use for targeted delivery of imaging agents. Torchilin VP Immunomethods; 1994 Jun; 4(3):244-58. PubMed ID: 7820455 [TBL] [Abstract][Full Text] [Related]
11. The effects of polyethyleneglycol (PEG)-derived lipid on the activity of target-sensitive immunoliposome. Ng K; Zhao L; Liu Y; Mahapatro M Int J Pharm; 2000 Jan; 193(2):157-66. PubMed ID: 10606778 [TBL] [Abstract][Full Text] [Related]
12. A modified protocol for efficient DNA encapsulation into pegylated immunoliposomes (PILs). Skjørringe T; Gjetting T; Jensen TG J Control Release; 2009 Oct; 139(2):140-5. PubMed ID: 19545595 [TBL] [Abstract][Full Text] [Related]
13. Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro. Kirpotin D; Park JW; Hong K; Zalipsky S; Li WL; Carter P; Benz CC; Papahadjopoulos D Biochemistry; 1997 Jan; 36(1):66-75. PubMed ID: 8993319 [TBL] [Abstract][Full Text] [Related]
14. Interference of macrophages with immunotargeting of liposomes. Koning GA; Kamps JA; Scherphof GL J Liposome Res; 2002; 12(1-2):107-19. PubMed ID: 12604044 [TBL] [Abstract][Full Text] [Related]
15. Immunoliposomes for Targeted Delivery of an Antifibrotic Drug. Schuster L; Seifert O; Vollmer S; Kontermann RE; Schlosshauer B; Hartmann H Mol Pharm; 2015 Sep; 12(9):3146-57. PubMed ID: 26181293 [TBL] [Abstract][Full Text] [Related]
16. [Production and characteristics of PEGylated immunoliposome transport vectors specific for neural tissue astrocytes]. Chekhonin VP; Zhirkov IuA; Gurina OI; Lebedev SV; Dmitrieva TB; Semenova AV; Iaglova TV; Riabinina AE Biomed Khim; 2005; 51(3):276-86. PubMed ID: 16104390 [TBL] [Abstract][Full Text] [Related]
17. Ex-vivo/in-vitro anti-polyethylene glycol (PEG) immunoglobulin M production from murine splenic B cells stimulated by PEGylated liposome. Abu Lila AS; Ichihara M; Shimizu T; Ishida T; Kiwada H Biol Pharm Bull; 2013; 36(11):1842-8. PubMed ID: 24189428 [TBL] [Abstract][Full Text] [Related]
19. Preparation of immunoliposomes bearing poly(ethylene glycol)-coupled monoclonal antibody linked via a cleavable disulfide bond for ex vivo applications. Mercadal M; Domingo JC; Petriz J; Garcia J; de Madariaga MA Biochim Biophys Acta; 2000 Dec; 1509(1-2):299-310. PubMed ID: 11118541 [TBL] [Abstract][Full Text] [Related]
20. Attachment of antibodies to sterically stabilized liposomes: evaluation, comparison and optimization of coupling procedures. Hansen CB; Kao GY; Moase EH; Zalipsky S; Allen TM Biochim Biophys Acta; 1995 Nov; 1239(2):133-44. PubMed ID: 7488618 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]